Cargando…
The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-rel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544656/ https://www.ncbi.nlm.nih.gov/pubmed/37790035 http://dx.doi.org/10.7759/cureus.44529 |
_version_ | 1785114546218729472 |
---|---|
author | Gohel, Shruti Kalarikkal, Zeid Lavingia, Viraj Mankad, Jigar |
author_facet | Gohel, Shruti Kalarikkal, Zeid Lavingia, Viraj Mankad, Jigar |
author_sort | Gohel, Shruti |
collection | PubMed |
description | The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-related adverse events (irAEs) are relatively rare but significant. Diagnostic challenges exist in distinguishing DIREs from disease sequelae. Efforts are needed to develop evidence-based strategies for managing DIREs as long-term survival with ICIs becomes possible. This case study highlights delayed neurological immune-related adverse events (NirAEs) encountered during pembrolizumab treatment, emphasizing the need for accurate diagnosis and prompt management. Reporting practices in immunotherapy trials hinder accurate assessment of DIREs. Close monitoring, accurate diagnosis, and timely corticosteroid administration are vital for effective DIRE management. |
format | Online Article Text |
id | pubmed-10544656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-105446562023-10-03 The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy Gohel, Shruti Kalarikkal, Zeid Lavingia, Viraj Mankad, Jigar Cureus Neurology The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-related adverse events (irAEs) are relatively rare but significant. Diagnostic challenges exist in distinguishing DIREs from disease sequelae. Efforts are needed to develop evidence-based strategies for managing DIREs as long-term survival with ICIs becomes possible. This case study highlights delayed neurological immune-related adverse events (NirAEs) encountered during pembrolizumab treatment, emphasizing the need for accurate diagnosis and prompt management. Reporting practices in immunotherapy trials hinder accurate assessment of DIREs. Close monitoring, accurate diagnosis, and timely corticosteroid administration are vital for effective DIRE management. Cureus 2023-09-01 /pmc/articles/PMC10544656/ /pubmed/37790035 http://dx.doi.org/10.7759/cureus.44529 Text en Copyright © 2023, Gohel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Gohel, Shruti Kalarikkal, Zeid Lavingia, Viraj Mankad, Jigar The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title | The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title_full | The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title_fullStr | The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title_full_unstemmed | The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title_short | The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy |
title_sort | immune system’s echo: the phenomenon of delayed neurological immune-related adverse events (niraes) in adjuvant immunotherapy |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544656/ https://www.ncbi.nlm.nih.gov/pubmed/37790035 http://dx.doi.org/10.7759/cureus.44529 |
work_keys_str_mv | AT gohelshruti theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT kalarikkalzeid theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT lavingiaviraj theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT mankadjigar theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT gohelshruti immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT kalarikkalzeid immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT lavingiaviraj immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy AT mankadjigar immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy |